-
The Effects of Disease-Modifying Antirheumatic Drugs on Cardiovascular Risk in Inflammatory Joint Diseases: Current Evidence and Uncertainties
04 Aug 2025 05:52 GMT
… from antiplatelet agents or statins.22
Sun et … However, large-scale clinical trials with definitive cardiovascular outcomes … that five years of etanercept treatment in patients with PsA … #47;/www.fda.gov/drugs/drug-safety-and-availability. Accessed …
-
Adalimumab, Etanercept Biosimilars Deliver Real-World Results for Juvenile Idiopathic Arthritis
29 Jul 2025 21:50 GMT
… Promising Equivalence
Adult clinical trials have demonstrated that … NOR-SWITCH (NCT02148640) trial later showed noninferiority after … of etanercept biosimilars compared with the originator for treatment of … of originator to biosimilar drug switch in juvenile …
-
Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution
29 Jul 2025 11:30 GMT
… Drug Administration (FDA … medicines that block tumor necrosis factor, such as Enbrel® (etanercept … doctor whether you should receive any vaccines before you begin treatment with ARCALYST.
Medicines …
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
SELECTED …
-
Biocon Biologics launches Nepexto, a Biosimilar to Enbrel (Etanercept), in Australia
25 Jul 2025 10:51 GMT
… a Biosimilar to Enbrel (Etanercept), in Australia
July 25 … | News
Etanercept is used in the treatment of autoimmune diseases … the reference product Enbrel® (Etanercept), in Australia.
Nepexto® … medicines, to expand access to patients in Australia.
Etanercept …
-
Successful Treatment with Secukinumab in a Psoriasis Patient on Hemodialysis
22 Jul 2025 17:06 GMT
… , with no obvious triggers. His medical history included a diagnosis of … patient 12 months after secukinumab treatment.
Following a multidisciplinary consultation, subcutaneous …
12. Cassano N, Vena GA. Etanercept treatment in a hemodialysis patient with …
-
Volume Fueling Rise in Part D Specialty Derm Drug Spending
18 Jul 2025 09:24 GMT
… specialty drugs were introduced before 2013: adalimumab (Humira), etanercept (Enbrel … Dermatological Treatment that annual spending on immunomodulator medications by Medicare Part … Eli Lilly, Equillium, ASLAN Pharmaceuticals, Boehringer Ingelheim, Figure 1, …
-
Medicare Price Negotiations Will Slow Biosimilar Momentum, Widening Market Gap
16 Jul 2025 20:58 GMT
… Enbrel (etanercept) have been approved by the FDA, with … crucial mechanism to lower treatment costs for complex … 47;biosimilar-approvals
6. Medicare drug price negotiation has chilling … 47;press-releases/medicare-drug-price-negotiation-has-chilling- …
-
What Could Lower US Drug Prices Cost the Rest of the World?
16 Jul 2025 01:48 GMT
… drive down US drug prices, the pharmaceutical industry has been … pricing models for essential medicines in lower-income countries, … For example, Enbrel® (etanercept), a drug for treating rheumatoid arthritis, … for the biotech industry,” concluded Seyf.
-
Patients With RA and Cancer Seek More Clarity, Collaboration in Treatment Decisions
09 Jul 2025 23:46 GMT
… and drug interactions, especially concerning tumor necrosis factor inhibitors like etanercept and … contributing to treatment decisions included prior experiences with RA medications, test results … , and that “some doctors will just use doctors’ terms, but they …
-
Beyond the Label: Evaluating Bimekizumab’s Mental Health Profile in Psoriasis Treatment
07 Jul 2025 21:21 GMT
… etanercept.6
Favorable safety data: In pooled clinical trials, … initiating treatment, clinicians should conduct pre-treatment screening using … with supportive clinical trial and real-world … dermatology physician assistant and medical writer in Connecticut. …